Roivant Sciences Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | +0.0% | +0.0% | +217.9% | +16.9% | -36.1% | -76.2% | |
| – | +108.2% | -30.7% | +565.0% | -61.5% | -8.3% | +44.8% | +19.8% | |
| – | – | – | +50.9% | +24.1% | – | – | – | |
| – | -69.2% | +370.3% | -78.1% | -59.6% | +200.0% | -504.8% | – | |
| – | -56.9% | +18.1% | +200.3% | -27.2% | -89.1% | +232.8% | +78.5% | |
| – | – | -101.9% | – | -114.6% | – | -133.9% | -61.4% | |
| – | – | – | – | – | -96.3% | – | – | |
| – | +16,014.8% | -100.0% | – | – | +200.9% | -136,086.5% | -75.3% | |
| – | -70.6% | -71.4% | +0.0% | +776.1% | -123.7% | +71.8% | -100.0% | |
| – | -71.7% | +110.1% | -32.8% | +62.8% | -16.0% | -390.9% | – | |
| – | +19.4% | -109.5% | – | – | – | -178.7% | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.